A similar decreasing trend of PPARα, PPARδ, and SIRT1 expression in the liver and kidney was observed in HFD mice with steatohepatitis and CKD (Figures 3(c), 3(e), 3(f), and 4(a)). Here, PPARA is linked to chronic kidney disease.